Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation
Jacobs, U.; Ferber, J.; Klehr, H.U.
Transplantation Proceedings 26(6): 3121
1994
ISSN/ISBN: 0041-1345 PMID: 7998088 Document Number: 435687
Document emailed within 1 workday
Related Documents
Rajcáni, J.; Sabó, A.; Mucha, V.; Kostál, M.; Compel, P. 1995: Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation Acta Virologica 39(1): 37-49Terleth, C.; van Laar, T.; Schouten, R.; van Steeg, H.; Hodemaekers, H.; Wormhoudt, T.; Cornelissen-Steijger, P.D.; Abrahams, P.J.; van der Eb, A.J. 1997: A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients Cancer Research 57(19): 4384-4392
Boulinguez, S.; Rogez, S. 1997: Herpes simplex virus: mechanism of latency and reactivation phases Annales de Dermatologie et de Venereologie 124(5): 409-415
Uchakin, P.N.; Stowe, R.P.; Paddon-Jones, D.; Tobin, B.W.; Ferrando, A.A.; Wolfe, R.R. 2007: Cytokine secretion and latent herpes virus reactivation with 28 days of horizontal hypokinesia Aviation Space and Environmental Medicine 78(6): 608-612
Aguilar, L.; Giménez, M.J.; Prieto, J. 2005: Is prevention of reactivation of herpes simplex 1 virus necessary in cosmetic surgery and dermatological procedures? Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 18(2): 118-123
Openshaw, H.; Puga, A.; Notkins, A.L. 1979: Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation Federation Proceedings 38(13): 2660-2664
Hofmann, M.; Engels, M.; Metzler, A.E.; Wyler, R. 1986: Reactivation of a latent bovine herpes mamillitis virus (BHV-2) infection in an animal with questionable IBR serology Schweizer Archiv für Tierheilkunde 128(6): 289-297
Sheridan, J.F.; Beck, M.; Smith, C.C.; Aurelian, L. 1987: Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro Journal of Immunology 138(4): 1234-1239
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cvjetković, D.; Jovanović, J.; Hrnjaković-Cvjetković, I.; Brkić, S.; Bogdanović, M. 1999: Reactivation of herpes zoster infection by varicella-zoster virus Medicinski Pregled 52(3-5): 125-128
Kubota, Y.; Gaither, T.A.; Cason, J.; O'Shea, J.J.; Lawley, T.J. 1987: Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells Journal of Immunology 138(4): 1137-1142
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Sachithanandham, J.; Kannangai, R.; Abraham, A.M.; Fletcher, G.J.; Abraham, O.C.; Daniel, D.; Pulimood, S.A. 2013: Human herpes virus-8 infections among subjects with human immunodeficiency virus infection and normal healthy individuals in India Intervirology 56(4): 253-257
Kreis, H.A.; Ponticelli, C. 2001: Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors Transplantation 71(11 Suppl): Ss5-Ss9
Bruce, C.B.; Pearson, C.K. 1983: A helix-destabilising protein from herpes simplex virus type I infected cells which specifically stimulates the virus induced DNA polymerase activity in vitro Biochemical and Biophysical Research Communications 116(1): 327-334
Fagan, W.A.; Collins, P.C.; Pulitzer, D.R. 1996: Verrucous herpes virus infection in human immunodeficiency virus patients Archives of Pathology and Laboratory Medicine 120(10): 956-958
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Keller, M.J.; Klotman, M.E.; Herold, B.C. 2003: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus American Journal of Reproductive Immunology 49(5): 279-284